KOCHURANI THOMAS: Open Payments
NPI 1699315531 · CLARKSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 68 payments from 16 companies in 2025. Trend: 2023 $104 · 2024 $1,246 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $199 |
| ABBVIE INC. | 14 | $187 |
| E.R. Squibb & Sons, L.L.C. | 8 | $142 |
| Axsome Therapeutics, Inc. | 6 | $126 |
| Tris Pharma Inc | 5 | $96 |
| Indivior Inc. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| Alkermes, Inc. | 4 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
Products named: UZEDY, COBENFY, VRAYLAR, Auvelity, Dyanavel XR, SUBLOCADE, CAPLYTA, INGREZZA.
Industry payments across IN — which companies pay providers there.
